03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Api-Loprost : | |
Type | Medicine Authorised |
Originator | Xalatan |
Agent | Germanos Health Care Supplies |
Distributor | Germanos Health Care Supplies |
Laboratory | API |
Responsible Party | Amman Pharmaceutical Industries |
Origin | Jordan |
Manufacturer | Amman Pharmaceutical Industries |
Manufacturing Type | G |
Origin | Jordan |
ATC | S01EE01 |
Api-Loprost :
Api-Loprost :
Api-Loprost :
Api-Loprost :
Api-Loprost :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Angina pectoris | Very rare |
Arthralgia (Pain joint) (Joint ache) | Not known |
Asthma | Rare |
Asthma exacerbation | Rare |
Blepharitis | Common |
Burning sensation in eye | Very Common |
Cephalea | Not known |
Chest pain | Very rare |
Conjunctival hyperaemia (Conjunctival redness) (Conjunctival injection) | Very Common |
Conjunctivitis | Uncommon |
Corneal erosion | Rare |
Distichiasis | Rare |
Dry eye | Uncommon |
Dyspnoea (dyspnea) | Rare |
Eye irritation | Very Common |
Eye pain | Common |
Eye pruritus | Very Common |
Eyelash changes | Very Common |
Eyelid oedema | Uncommon |
Eyelid vellus hair changes | Very Common |
Eyes stinging (Ocular stinging) | Very Common |
Growth of eyelashes abnormal | Rare |
Herpetic keratitis | Not known |
Hyperpigmentation of eyelid | Rare |
Iris cyst | Not known |
Iris hyperpigmentation | Very Common |
Iritis | Rare |
Keratitis | Uncommon |
Lid changes | Very rare |
Macular oedema | Rare |
Myalgia | Not known |
Oedema | Rare |
Palpitations | Not known |
Periorbital changes | Very rare |
Periorbital oedema | Rare |
Photophobia | Common |
Punctate epithelial erosion | Common |
Sensation of foreign body | Very Common |
Skin rash | Uncommon |
Uveitis | Rare |
Vertigo | Not known |
Vision blurred | Uncommon |
Api-Loprost :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Api-Loprost MoH 10542 :
Form | Eye drops, solution |
Packaging | Bottle |
Package Size | 2.5ml |
Strength | 50µg/ml |
Public Price | 447499.55 L.L. |
Stratum | A1 |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 36118/1 |
Submission date | 12/03/2018 |
Registration Year | 04/05/2021 |
Pending Year | 10/10/2019 |
Pending Reason | Incomplete file |
Price Comparison
● Country: | Lebanon | |
● Form: | Eye drops, solution | |
● Package Size: | 2.5ml | |
● Public Price: | 447499.55 LBP | ( 447,499.55 LBP ) |
● Pack size unit used: | 50 | |
● Cost/Unit: | 8949,99 LBP | ( 8,949.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | Jordan | |
● Package Size: | 2,5ml | |
● Public Price: | 6.36 JOD | ( 796,405.56 LBP ) |
● Pack size unit used: | 50 | |
● Cost/Unit: | 0,1272 JOD | ( 0.00 LBP ) |
● Pharmacy Price: | 4.86 JOD | ( 608574.06 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 02/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 2.5 ml Bottle | |
● Public Price: | 35.5 AED | ( 857,715.50 LBP ) |
● Pack size unit used: | 50 | |
● Cost/Unit: | 0,71 AED | ( 0.00 LBP ) |
● Pharmacy Price: | 28.7 AED | ( 693420.7 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File